CN103932993A - 一种含有艾塞那肽或其盐及类似物的组合物 - Google Patents
一种含有艾塞那肽或其盐及类似物的组合物 Download PDFInfo
- Publication number
- CN103932993A CN103932993A CN201410153581.2A CN201410153581A CN103932993A CN 103932993 A CN103932993 A CN 103932993A CN 201410153581 A CN201410153581 A CN 201410153581A CN 103932993 A CN103932993 A CN 103932993A
- Authority
- CN
- China
- Prior art keywords
- microsphere
- solution
- exenatide
- polyvinyl alcohol
- value
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
实验编号 | 包封率 |
实施例1 | 85.4% |
实施例2 | 91.6% |
实施例3 | 99.1% |
实施例4 | 90.3% |
实施例5 | 88.3% |
实施例6 | 93.1% |
实施例7 | 92.5% |
对比例1 | 64.2% |
对比例2 | 69.1% |
对比例3 | 68.2% |
对比例4 | 66.4% |
实验编号 | 跨距 |
实施例1 | 0.76 |
实施例2 | 0.74 |
实施例3 | 0.24 |
实施例4 | 0.78 |
实施例5 | 0.64 |
实施例6 | 0.44 |
实施例7 | 0.41 |
对比例1 | 3.31 |
对比例2 | 3.29 |
对比例3 | 2.04 |
对比例4 | 2.37 |
实验编号 | 聚乙烯醇残留 |
实施例1 | 0.0067% |
实施例2 | 0.0054% |
实施例3 | 0.0019% |
实施例4 | 0.0068% |
实施例5 | 0.0079% |
实施例6 | 0.0074% |
实施例7 | 0.0043% |
对比例1 | 0.0191% |
对比例2 | 0.0223% |
对比例3 | 0.0187% |
对比例4 | 0.0157% |
Claims (10)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410153581.2A CN103932993B (zh) | 2014-04-16 | 2014-04-16 | 一种含有艾塞那肽或其盐的组合物 |
EP15779307.6A EP3132790A4 (en) | 2014-04-16 | 2015-04-16 | Exenatide-containing composition and preparation method therefor |
US15/304,528 US20170035856A1 (en) | 2014-04-16 | 2015-04-16 | Exenatide-containing composition and preparation method therefor |
JP2016562940A JP2017511371A (ja) | 2014-04-16 | 2015-04-16 | エクセナチド含有組成物及びその製造方法 |
PCT/CN2015/076688 WO2015158270A1 (zh) | 2014-04-16 | 2015-04-16 | 一种含有艾塞那肽的组合物及其制备方法 |
US15/803,807 US20180117123A1 (en) | 2014-04-16 | 2017-11-05 | Exenatide-containing composition and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410153581.2A CN103932993B (zh) | 2014-04-16 | 2014-04-16 | 一种含有艾塞那肽或其盐的组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103932993A true CN103932993A (zh) | 2014-07-23 |
CN103932993B CN103932993B (zh) | 2016-02-03 |
Family
ID=51181051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410153581.2A Active CN103932993B (zh) | 2014-04-16 | 2014-04-16 | 一种含有艾塞那肽或其盐的组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103932993B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104434817A (zh) * | 2014-09-17 | 2015-03-25 | 黑龙江泰华源生物技术有限责任公司 | 一种利拉鲁肽的注射用缓释微球制剂 |
WO2015158270A1 (zh) * | 2014-04-16 | 2015-10-22 | 山东绿叶制药有限公司 | 一种含有艾塞那肽的组合物及其制备方法 |
CN108606957A (zh) * | 2016-12-13 | 2018-10-02 | 南京星银药业集团有限公司 | 一种含索马鲁肽的口服缓释制剂及其制备方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102198103A (zh) * | 2011-05-30 | 2011-09-28 | 深圳翰宇药业股份有限公司 | 一种稳定的艾塞那肽缓释微球制剂及制备方法 |
-
2014
- 2014-04-16 CN CN201410153581.2A patent/CN103932993B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102198103A (zh) * | 2011-05-30 | 2011-09-28 | 深圳翰宇药业股份有限公司 | 一种稳定的艾塞那肽缓释微球制剂及制备方法 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015158270A1 (zh) * | 2014-04-16 | 2015-10-22 | 山东绿叶制药有限公司 | 一种含有艾塞那肽的组合物及其制备方法 |
CN104434817A (zh) * | 2014-09-17 | 2015-03-25 | 黑龙江泰华源生物技术有限责任公司 | 一种利拉鲁肽的注射用缓释微球制剂 |
CN104434817B (zh) * | 2014-09-17 | 2018-02-13 | 黑龙江泰华源生物技术有限责任公司 | 一种利拉鲁肽的注射用缓释微球制剂 |
CN108606957A (zh) * | 2016-12-13 | 2018-10-02 | 南京星银药业集团有限公司 | 一种含索马鲁肽的口服缓释制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103932993B (zh) | 2016-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102085355B (zh) | 一种利拉鲁肽长效微球注射剂及其制备方法 | |
CN103932993B (zh) | 一种含有艾塞那肽或其盐的组合物 | |
EP3006050A1 (en) | Low molecular weight polyethylene glycol drug conjugates having improved drug biological activity | |
CN107811967A (zh) | 抗寄生虫药物原位固化缓释注射剂及其制备方法 | |
CN103222963B (zh) | 生长抑素冻干粉针剂 | |
CN100588399C (zh) | 一种注射用替莫唑胺冻干粉针剂及其制备方法 | |
KR20230041032A (ko) | 중합체 복합 제제를 포함하는 제제 및 조성물 | |
CN100496487C (zh) | 米格列奈钙制剂及其制备方法 | |
CN104644578A (zh) | 磷酸西格列汀组合物片剂及其制备方法 | |
El Maghraby et al. | Development of liquid oral sustained release formulations of nateglinide: in vitro and in vivo evaluation | |
CN104688678B (zh) | 一种甘精胰岛素注射液的制备方法及其制备的甘精胰岛素注射液 | |
CN103494780B (zh) | 一种注射用加米霉素组合物冻干粉及制备方法 | |
CN102657871A (zh) | 一种口服缓释制剂、包载材料及制备方法 | |
US20180117123A1 (en) | Exenatide-containing composition and preparation method thereof | |
CN101947207B (zh) | 一种酒石酸泰乐菌素微球的制备方法 | |
CN116407509A (zh) | 一种利格列汀长效缓释微球及其制备方法 | |
CN101244259B (zh) | 一种注射用胸腺肽α1缓释微球制剂及其制备方法 | |
CN105342999A (zh) | 艾塞那肽口服纳米粒 | |
CN113288876B (zh) | 一种氟苯尼考缓释颗粒的质量评价与控制方法 | |
CN102552160B (zh) | 兽用甲磺酸达氟沙星缓释微球制剂及其制备方法与应用 | |
CN105769771A (zh) | 一种艾塞那肽缓释微球组合物及其制备方法 | |
CN103932992B (zh) | 一种含有艾塞那肽的组合物 | |
CN101444528A (zh) | Gip分泌抑制剂 | |
CN103432092B (zh) | 一种瑞格列奈的缓释制剂 | |
CN108289897A (zh) | 一种瑞马唑仑的药物组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 264003 Yantai hi tech Zone, Shandong venture Road No. 15 Applicant after: Shandong Luye Pharma Co., Ltd. Address before: 264003 Laishan, Shandong Province Bao Road, No. 9 District, No. Applicant before: Shandong Luye Pharma Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Tao Inventor after: Dai Xinru Inventor after: Wen Xinjun Inventor after: Wang Qilin Inventor after: Xu Qianqian Inventor after: Sun Lifang Inventor after: Meng Ying Inventor after: Li Ju Inventor before: Wang Tao Inventor before: Wang Qilin Inventor before: Xu Qianqian Inventor before: Sun Lifang Inventor before: Meng Ying Inventor before: Li Ju |